Amithraz Balgobin, 36, allegedly attacked Amaratial Mistry at a property in Streatham, south London, on Friday July 4.

A 77-year-old Vermont man was killed on Sunday afternoon while attempting to rescue a turtle on Interstate 95 in Indian River ...

The 87-year-old stopped to try and take the turtle to safety, but ended up being struck by an oncoming vehicle.

DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...

Maria Pasqual was a flower farmer in Maili, loved by those who encountered her. The family who lives next door to her farm ...

A missing elderly woman with dementia has been found deceased in Daviess County. Lola Davis, 89, of Mt. Vernon, Indiana, went ...

When Kiara Miller noticed Mr. Johnson sitting alone in his usual booth at a Blairsville diner, she knew something was up.

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

The suspect told the victim to “shut up,'' sparking a dispute in which she became "aggressive'' and he walloped her multiple ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.